Hastings ML[au] - Search Results

Year	Number of Results
1965	1
1967	1
1997	1
2000	1
2001	3
2004	1
2005	2
2006	2
2007	3
2009	2
2010	3
2011	3
2012	5
2013	5
2014	3
2015	2
2016	6
2017	5
2018	6
2019	3
2020	8
2021	1

1

Therapeutic efficacy of antisense oligonucleotides in mouse models of CLN3 Batten disease.

Centa JL, Jodelka FM, Hinrich AJ, Johnson TB, Ochaba J, Jackson M, Duelli DM, Weimer JM, Rigo F, Hastings ML. Centa JL, et al. Among authors: hastings ml. Nat Med. 2020 Sep;26(9):1444-1451. doi: 10.1038/s41591-020-0986-1. Epub 2020 Jul 27. Nat Med. 2020. PMID: 32719489 Free PMC article.

2

Gene therapy restores auditory and vestibular function in a mouse model of Usher syndrome type 1c.

Pan B, Askew C, Galvin A, Heman-Ackah S, Asai Y, Indzhykulian AA, Jodelka FM, Hastings ML, Lentz JJ, Vandenberghe LH, Holt JR, Géléoc GS. Pan B, et al. Among authors: hastings ml. Nat Biotechnol. 2017 Mar;35(3):264-272. doi: 10.1038/nbt.3801. Epub 2017 Feb 6. Nat Biotechnol. 2017. PMID: 28165476 Free PMC article.

3

Fetal antisense oligonucleotide therapy for congenital deafness and vestibular dysfunction.

Wang L, Kempton JB, Jiang H, Jodelka FM, Brigande AM, Dumont RA, Rigo F, Lentz JJ, Hastings ML, Brigande JV. Wang L, et al. Among authors: hastings ml. Nucleic Acids Res. 2020 May 21;48(9):5065-5080. doi: 10.1093/nar/gkaa194. Nucleic Acids Res. 2020. PMID: 32249312 Free PMC article.

4

Antisense oligonucleotide-mediated correction of CFTR splicing improves chloride secretion in cystic fibrosis patient-derived bronchial epithelial cells.

Michaels WE, Bridges RJ, Hastings ML. Michaels WE, et al. Among authors: hastings ml. Nucleic Acids Res. 2020 Jul 27;48(13):7454-7467. doi: 10.1093/nar/gkaa490. Nucleic Acids Res. 2020. PMID: 32520327 Free PMC article.

5

Antisense Oligonucleotides for the Treatment of Inner Ear Dysfunction.

Hastings ML, Jones TA. Hastings ML, et al. Neurotherapeutics. 2019 Apr;16(2):348-359. doi: 10.1007/s13311-019-00729-0. Neurotherapeutics. 2019. PMID: 30972560 Free PMC article. Review.

6

Identification of SRSF10 as a regulator of SMN2 ISS-N1.

Frederiksen SB, Holm LL, Larsen MR, Doktor TK, Andersen HS, Hastings ML, Hua Y, Krainer AR, Andresen BS. Frederiksen SB, et al. Among authors: hastings ml. Hum Mutat. 2021 Mar;42(3):246-260. doi: 10.1002/humu.24149. Epub 2020 Dec 16. Hum Mutat. 2021. PMID: 33300159

7

Fetal gene therapy and pharmacotherapy to treat congenital hearing loss and vestibular dysfunction.

Hastings ML, Brigande JV. Hastings ML, et al. Hear Res. 2020 Sep 1;394:107931. doi: 10.1016/j.heares.2020.107931. Epub 2020 Mar 5. Hear Res. 2020. PMID: 32173115 Free article. Review.

8

Splice-switching antisense oligonucleotides as therapeutic drugs.

Havens MA, Hastings ML. Havens MA, et al. Among authors: hastings ml. Nucleic Acids Res. 2016 Aug 19;44(14):6549-63. doi: 10.1093/nar/gkw533. Epub 2016 Jun 10. Nucleic Acids Res. 2016. PMID: 27288447 Free PMC article. Review.

9

RNA localization and co-translational interactions control RAB13 GTPase function and cell migration.

Moissoglu K, Stueland M, Gasparski AN, Wang T, Jenkins LM, Hastings ML, Mili S. Moissoglu K, et al. Among authors: hastings ml. EMBO J. 2020 Nov 2;39(21):e104958. doi: 10.15252/embj.2020104958. Epub 2020 Sep 18. EMBO J. 2020. PMID: 32946136 Free PMC article.

10

Splice-Switching Antisense Oligonucleotides Reduce LRRK2 Kinase Activity in Human LRRK2 Transgenic Mice.

Korecka JA, Thomas R, Hinrich AJ, Moskites AM, Macbain ZK, Hallett PJ, Isacson O, Hastings ML. Korecka JA, et al. Among authors: hastings ml. Mol Ther Nucleic Acids. 2020 Sep 4;21:623-635. doi: 10.1016/j.omtn.2020.06.027. Epub 2020 Jun 27. Mol Ther Nucleic Acids. 2020. PMID: 32736291 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results